Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1976 Sep;34(3):221–226. doi: 10.1038/bjc.1976.155

Macrophages and lymphoid tissues in mice with concomitant tumour immunity.

D S Nelson, R Kearney
PMCID: PMC2025175  PMID: 973997

Abstract

The growth in mice of subcutaneous isografts of any of 5 methylcholanthrene-induced fibrosarcomas was associated with macrophage stimulation, reflected in an increased incidence of DNA-synthesizing cells among marcophages in the uninjected peritoneal cavity. This occurred at some stage with 4 tumours that induced concomitant immunity and one that did not. Some degree of splenomegaly also occurred with all 5 tumours. The spleens of all the tumour-bearing mice showed histological evidence of increased haemopoietic activity. Histological changes in the lymphoid elements of the spleen were very different with different tumours, ranging from lymphoid stimulation to lymphoid atrophy. The lymph nodes draining the sites of primary isografts which induced concomitant immunity showed signs of stimulation in the paracortical areas, followed by plasmacytopoiesis in the medullary areas. Stimulation of the paracortical areas was not detected in the nodes draining sites of injection of a tumour not inducing concomitant immunity. Nodes draining the sites of challenge isografts in mice exhibiting concomitant immunity showed plasmacytopiesis.

Full text

PDF
221

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Blamey R. W., Crosby D. L., Baker J. M. Reticuloendothelial activity during the growth of rat sarcomas. Cancer Res. 1969 Feb;29(2):335–337. [PubMed] [Google Scholar]
  2. Bloom E. T. Quantitative detection of cytotoxic antibodies against tumor-specific antigens of murine sarcomas induced by 3-methylcholanthrene. J Natl Cancer Inst. 1970 Sep;45(3):443–453. [PubMed] [Google Scholar]
  3. Eccles S. A., Alexander P. Macrophage content of tumours in relation to metastatic spread and host immune reaction. Nature. 1974 Aug 23;250(5468):667–669. doi: 10.1038/250667a0. [DOI] [PubMed] [Google Scholar]
  4. Evans R., Alexander P. Mechanism of immunologically specific killing of tumour cells by macrophages. Nature. 1972 Mar 24;236(5343):168–170. doi: 10.1038/236168a0. [DOI] [PubMed] [Google Scholar]
  5. Fisher B., Taylor S., Levine M., Saffer E., Fisher E. R. Effect of Myobacterium bovis (strain Bacillus Calmette-Guérin) on macrophage production by the bone marrow of tumor-bearing mice. Cancer Res. 1974 Jul;34(7):1668–1670. [PubMed] [Google Scholar]
  6. Hibbs J. B., Jr Macrophage nonimmunologic recognition: target cell factors related to contact inhibition. Science. 1973 May 25;180(4088):868–870. doi: 10.1126/science.180.4088.868. [DOI] [PubMed] [Google Scholar]
  7. Izumi S., Penrose J. M., More D. G., Nelson D. S. Further observations on the immunological induction of DNA synthesis in mouse peritoneal macrophages. Role of products of activated lymphocytes. Int Arch Allergy Appl Immunol. 1975;49(5):573–584. doi: 10.1159/000231439. [DOI] [PubMed] [Google Scholar]
  8. Jurin M., Drewinko B. Natural history of mouse syngeneic lymphoma. Morphologic and immunologic aspects. Am J Pathol. 1974 Nov;77(2):213–236. [PMC free article] [PubMed] [Google Scholar]
  9. Kearney R., Basten A., Nelson D. S. Cellular basis for the immune response to methylcholanthrene-induced tumors in mice. Heterogeneity of effector cells. Int J Cancer. 1975 Mar 15;15(3):438–450. doi: 10.1002/ijc.2910150310. [DOI] [PubMed] [Google Scholar]
  10. Kearney R., Nelson D. S. Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity. Aust J Exp Biol Med Sci. 1973 Dec;51(6):723–735. doi: 10.1038/icb.1973.70. [DOI] [PubMed] [Google Scholar]
  11. Keller R. Cytostatic elimination of syngeneic rat tumor cells in vitro by nonspecifically activated macrophages. J Exp Med. 1973 Sep 1;138(3):625–644. doi: 10.1084/jem.138.3.625. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Konda S., Nakao Y., Smith R. T. The stimulatory effect of tumor bearing upon the T- and B-cell subpopulations of the mouse spleen. Cancer Res. 1973 Oct;33(10):2247–2256. [PubMed] [Google Scholar]
  13. Konda S., Smith R. T. The effects of tumor bearing upon changes in cell distribution and membrane antigen characteristics in murine spleen and thymus cell subpopulations. Cancer Res. 1973 Aug;33(8):1878–1884. [PubMed] [Google Scholar]
  14. Krüger G. Morphologic studies of lymphoid tissues during the growth of an isotransplanted mouse tumor. J Natl Cancer Inst. 1967 Jul;39(1):1–15. [PubMed] [Google Scholar]
  15. LOCKNER D., SLETTEN K., DE HEVESY G. STUDIES ON CANCER ANAEMIA: ORGAN WEIGHTS, BLOOD VALUES AND IRON METABOLISM IN NORMAL AND TUMOUR-BEARING MICE. Br J Cancer. 1963 Jun;17:328–354. doi: 10.1038/bjc.1963.47. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Magarey C. J., Baum M. Reticulo-endothelial activity in humans with cancer. Br J Surg. 1970 Oct;57(10):748–752. doi: 10.1002/bjs.1800571013. [DOI] [PubMed] [Google Scholar]
  17. More D. G., Penrose J. M., Kearney R., Nelson D. S. Immunological induction of DNA synthesis in mouse peritoneal macrophages. An expression of cell-mediated-immunity. Int Arch Allergy Appl Immunol. 1973;44(5):611–630. doi: 10.1159/000230965. [DOI] [PubMed] [Google Scholar]
  18. Nelson D. S. Immunity to infection, allograft immunity and tumour immunity: parallels and contrasts. Transplant Rev. 1974;19(0):226–254. doi: 10.1111/j.1600-065x.1974.tb00134.x. [DOI] [PubMed] [Google Scholar]
  19. North R. J., Kirstein D. P., Tuttle R. L. Subversion of host defense mechanisms by murine tumors. II. Counter-influence of concomitant antitumor immunity. J Exp Med. 1976 Mar 1;143(3):574–584. doi: 10.1084/jem.143.3.574. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. North R. J. The relative importance of blood monocytes and fixed macrophages to the expression of cell-mediated immunity to infection. J Exp Med. 1970 Sep 1;132(3):521–534. doi: 10.1084/jem.132.3.521. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Pimm M. V., Baldwin R. W. BCG immunotherapy of rat tumours in athymic nude mice. Nature. 1975 Mar 6;254(5495):77–78. doi: 10.1038/254077a0. [DOI] [PubMed] [Google Scholar]
  22. Rosenau W., Moon H. D. Cellular reactions to methylcholanthrene-induced sarcomas transplanted to isogenic mice. Lab Invest. 1966 Jul;15(7):1212–1224. [PubMed] [Google Scholar]
  23. Simes R. J., Kearney R., Nelson D. S. Role of a non-committed accessory cell in the in vivo suppression of a syngeneic tumour by immune lymphocytes. Immunology. 1975 Aug;29(2):343–351. [PMC free article] [PubMed] [Google Scholar]
  24. Smith R. T., Konda S. The stimulatory effects of bearing primary methylcholanthrene-induced tumors upon the murine lymphoreticular system. Int J Cancer. 1973 Nov 15;12(3):577–588. doi: 10.1002/ijc.2910120306. [DOI] [PubMed] [Google Scholar]
  25. Snodgrass M. J., Lowrey D. S., Hanna M. G., Jr Changes induced by lactic dehydrogenase virus in thymus and thymus-dependent areas of lymphatic tissue. J Immunol. 1972 Apr;108(4):877–892. [PubMed] [Google Scholar]
  26. Woodruff M., Dunbar N., Ghaffar A. The growth of tumours in T-cell deprived mice and their response to treatment with Corynebacterium parvum. Proc R Soc Lond B Biol Sci. 1973 Aug 31;184(1074):97–102. doi: 10.1098/rspb.1973.0034. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES